Enter value and hit "Enter" Enter value and hit "Enter" Enter value and hit "Enter" Enter box size and hit "Enter" Enter reversal and hit "Enter" or Auto Select Settings Done Edit Settings... Delete Study Study Done Create Custom Theme Candle Color Candle Wick Candle Border Line/Bar Chart Mountain Color Background Grid Lines Date Dividers Axis Text Save Choose Timezone To set your timezone use the location button below, or scroll through the following list...
Shasun Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2, crore.
The company management includes R Kannan - Chairman, S Abhaya Kumar - Managing Director, S Devendra - Whole Time Director, S Vimal Kumar - Whole Time Director, R Sundara Rajan - Independent Director, N Subramanian - Independent Director, Arun Chandra Karmakar - Director, Taru Mayur - Director, Taru Rajesh Mardia - Non Executive Director, Sunny Sharma - Non Executive Director.
It is listed on the BSE with a BSE Code of 524552 and the NSE with an NSE Code of SHASUNPHAR.
Its Registered office is at Batra Centre, 3rd & 4th Floor,,28,Sardar Patel Road, Chennai (Madras),Tamil Nadu - 600032.
Their Registrars are Integrated Enterprises (India) Ltd.
This is a compound similar to trenbolone. Unlike previous "tren", this one actually converts in the body to trenbolone. Previous "tren" PHs converted to the structurally similar - but markedly weaker dienolone. Conversion to trenbolone should be high, so effects should be identical to the injectable form - with the exception of the famed "tren cough". Whatever the explanation for "tren cough" (and many have been suggested), since it's a reaction to the sudden parenteral introduction of some compound directly into the body, it's highly unlikely that any orally administered compound will have the same effect.